Nipocalimab, an anti-FcRn monoclonal antibody, in participants with moderate to severe active rheumatoid arthritis and inadequate response or intolerance to anti-TNF therapy: resul... by Taylor, PC, Schett, G, Huizinga, TW, Wang, Q, Ibrahim, F, Zhou, B, Liva, SG, Shaik, JSB, Xiong, Y, Leu, JH, Panchakshari, RA, Loza, MJ, Ma, K, Dhatt, H, Rojo Cella, R, Karyekar, CS, Cuff, CA, Gao, S, Fei, K